Cardival Medical plant in Guaymas, Sonora, recognized for Operational Excellence
Cardiva Medical, Inc., a California-based developer and manufacturer of vascular closure technologies, announced that its production facility in Guaymas, Sonora has been recognized for Operational Excellence from The Shingo Institute, part of the Jon M. Huntsman School of Business at Utah State University.
Based on a thorough assessment of organizational culture and operations, the plant was awarded the Bronze Medallion as recognition of the site’s ongoing commitment to operational excellence throughout all levels of the organization.
“Receipt of the Shingo Bronze Medallion signifies an organization’s mastery of fundamental tools and techniques for improving an organization’s operations,” said Ken Snyder, executive director at the Shingo Institute. “Organizations such as Cardiva that receive the Bronze Medallion are making great progress on their journey to achieving enterprise excellence.”
Built in 2014 to support growing sales volume of Cardiva’s vascular closure technologies, the Guaymas, Mexico facility is dedicated to manufacturing Cardiva’s Vascade Vascular Closure System and Catalyst Closure Wire.
Led by plant manager Jesus Beltran, the facility started implementation of the Shingo Principals as it was being designed and staffed, and since opening has grown the number of employees by over 700%.
The plant has also supplied product for the recently completed Ambulate Clinical Trial and will be the future manufacturing site of Vascade MVP – a first-of-its-kind mid-bore venous vascular closure device designed for multi-access electrophysiology procedures.
“True to the Shingo principles, Cardiva is committed to creating value for our customers by driving quality and delivering innovative vascular closure devices that help patients receive the best care possible,” said Justin Ballotta, Cardiva’s chief operating officer. “Implementing the Shingo principles has helped us create a culture committed to growth, continuous improvement, and lean processes, and we are grateful for the recognition and guidance from the Shingo Institute throughout this process.”
By implementing the Shingo Principals, Cardiva’s manufacturing facility has been able to support a three-year growth rate of 183%– a sales growth that recently earned Cardiva recognition on Inc. Magazine’s Inc. 5000 list as one of the fastest growing private companies in the United States.
Cardiva Medical, Inc. designs and develops vascular access management products that facilitate rapid hemostasis following diagnostic and interventional endovascular procedures. Since its founding, Cardiva has introduced a series of advanced vascular access management technologies that have been adopted by hundreds of leading medical centers.
Cardiva Medical will receive Shingo’s Bronze Medallion award during the Awards Gala at the 31st Shingo Conference held April 28–May 3, 2019, in Cincinnati, Ohio.